Yep I wasn't referring to PYC searching for new cancer drugs though it was more so in reference to them being able to deliver existing drugs to greater effect via the EET and peptides acting as carriers directly to hard to reach targets.
The problem with antibiotics and why big pharma left the space leaving the world in the dire position it now sits with lack of new treatments is it's just not profitable compared to cancer drugs or the like. People take them for a few days or few weeks and then it's done. Feds made a lot of moves to encourage big pharma back into the space to make it attractive hence why they have all been coming back in & many after a long absence - PYC has had a number of candidates that have hit hospital acquired infections & if I was going to take a guess that's probably right up there with the most profitable hence why big pharma all seem to be chasing them.
PYC Price at posting:
1.9¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)